Given its high aggressiveness, unclassified renal cell carcinoma (RCC) with medullary phenotype and SMARCB1 deficiency presents a poor prognosis, with a survival of four months for patients with metastases and seventeen months for those without metastases (34). This evidence concerns the gene SMARCB1 and renal cell carcinoma.